(Press-News.org) (MEMPHIS, Tenn. - May 20, 2015) Researchers led by St. Jude Children's Research Hospital scientists have developed a second-generation antibiotic that shows early effectiveness against common bacterial infections that pose a serious health threat to children and adults. The findings appear today in the scientific journal Science Translational Medicine.
The study marks the second time in recent years that St. Jude researchers have created promising antibiotics by changing the chemical structure of an old antibiotic named spectinomycin. Spectinomycin is a safe, but weak drug first introduced in the 1960s.
In this study, investigators built on research published in the 1980s to create new, more potent versions or analogs of spectinomycin. The analogs include one named 1950 that proved as effective as the antibiotic ampicillin at protecting mice from an often lethal strain of Streptococcus pneumonia. The bacterium cause pneumococcal infections, including pneumonia, meningitis, the ear infection otitis media and sepsis in humans.
In the laboratory, the spectinomycin analogs blocked the growth of strains of the pneumococcal bacteria resistant to commonly used antibiotics. The second-generation spectinomycins demonstrated increased antibacterial activity against Haemophilus influenza and Moraxella catarrhalis, which are additional common causes of respiratory infection. The spectinomycin analogs were also more effective against bacteria responsible for most cases of Legionnaires' disease and the sexually transmitted diseases gonorrhea and chlamydia.
"The growing problem of drug-resistant bacteria has created an urgent need for new antibiotics that use novel mechanisms to treat adults and children worldwide. Immune-compromised St. Jude patients undergoing treatment for other indications, as well as adults and children are particularly at risk from these types of secondary infections," said corresponding author Richard Lee, Ph.D., a member of the St. Jude Department of Chemical Biology and Therapeutics.
The U.S. Centers for Disease Control and Prevention estimates that drug-resistant bacteria sicken two million U.S. residents annually and cause about 23,000 deaths. Federal officials have called combating antibiotic resistance a national priority.
Lee's strategy has been to scour the medical literature from 20 or 30 years ago when antibiotics were plentiful and resistant bacteria were rare. He looks for natural products like spectinomycin that can be re-engineered using structure-based design to enhance the potency of existing drugs, reduce the risk of side effects and avoid antibiotic resistance.
In 2014, Lee and his colleagues used the approach to create a new class of antibiotics called spectinamides designed specifically for treatment of drug-resistant tuberculosis (TB). The drugs, which are still in development, use a novel mechanism to accumulate within the cell and inhibit protein synthesis leading to TB cell death.
In this study, researchers again used structure-based design to map and re-engineer how spectinomycin binds to the ribosomes of clinically important bacteria with a focus on generating compounds that work on a broader spectrum of disease-causing bacteria. Work published in the 1980s by researchers with the Upjohn Co., which later merged into Pfizer, helped jumpstart the St. Jude research.
Upjohn scientists had modified the chemical structure of spectinomycin, proving that the spectinomycin core could be chemically modified to improve potency. The project was later shelved in favor of other antibiotics.
Since then the structure of the ribosome has been determined. Technological advances also give researchers an atomic-level, 3-D model of spectinomycin bound to bacterial ribosomes. Researchers in this study used the Upjohn modification chemistry to create 20 new structure-guided versions of spectinomycin, including 1950 and three other analogs thatare the focus of this report.
"The re-engineered spectinomycin has a new hook it uses to enter a broad range of bacteria, bind to the ribosome and block protein synthesis," Lee said. He speculated that the redesign might also hinder the ability of bacteria to pump out the drug using a process called efflux before the medicine has a chance to work.
Laboratory tests showed the spectinomycin analogs were unlikely to cause serious side effects or interfere with other medications. Work on the analogs continues at St. Jude.
INFORMATION:
The first authors are Samanthi Waidyarachchi, of St. Jude, and David Bruhn, formerly of St. Jude. The other authors are Dora Madhura, Yasser Abdelrahman, Chetan Rathi, Robert Belland and Bernd Meibohm, all of the University of Tennessee Health Science Center, Memphis; Dimitri Shcherbakov, Stefan Duscha and Erik Böttger, all of the University of Zurich; and Zhong Zheng, Jiuyu Liu, Aman Singh, Robin Lee and Jason Rosch, all of St. Jude.
The study was funded in part by grants (AI090810, AI111449) from the National Institutes of Health and ALSAC.
St. Jude Media Relations Contacts
Carrie Strehlau
Desk: (901) 595-2295
Cell: (901) 297-9875
carrie.strehlau@stjude.org
Frannie Marmorstein
Desk: (901) 595-0221
Cell: (901) 379-6072
Frannie.marmorstein@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food--because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.
TORONTO, May 20, 2015 - The use of personalized music playlists with tempo-pace synchronization increases adherence to cardiac rehab by almost 70 per cent--according to a study published in Sports Medicine -Open.
"Cardiac rehab has been proven to improve long-term survival for someone who's had a heart event by 20 per cent," said Dr. David Alter, Senior Scientist, Toronto Rehab, University Health Network, and Institute for Clinical Evaluative Sciences. "Our challenge is there is a high drop-out rate for these programs and suboptimal adherence to the self-management of ...
Independent reproduction of other scientists' results is a cornerstone of solid research, but scientists are rarely recognized for successfully reproducing published findings, much less for demonstrating that scientific findings cannot be reproduced. However, failure to reproduce a finding may suggest doubt about the robustness of the original work, which carries implications for anyone looking to build on those findings.
University of Iowa neuroscientist Andrew Pieper unexpectedly found himself in the position of contradicting seemingly promising results published in ...
BUFFALO, N.Y. - A false tweet from a hacked account owned by the Associated Press (AP) in 2013 sent financial markets into a tailspin. The Dow Jones Industrial Average dropped 143.5 points and the Standard & Poor's 500 Index lost more than $136 billion of its value in the seconds that immediately followed the post.
Once the nature of the tweet was discovered, the markets corrected themselves almost as quickly as they were skewed by the bogus information, but the event, known as Hack Crash, demonstrates the need to better understand how social media data is linked to decision ...
Washington, DC--An unborn child's gender can affect the mother's risk of developing gestational diabetes or Type 2 diabetes later in life, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Gestational diabetes occurs when a pregnant woman has higher levels of glucose, or blood sugar, in the bloodstream than normal. Women who have been diagnosed with gestational diabetes face a greater risk of developing Type 2 diabetes in the future. As many as 9 percent of pregnant women develop gestational diabetes, according ...
Washington, DC--People who have metabolic syndrome are more likely to die from cardiovascular disease than people who do not have the condition, and having diabetes or high blood pressure worsens the risk, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Metabolic syndrome is a cluster of risk factors that raise the chances of developing heart disease, stroke and diabetes, according to the Hormone Health Network. The risk factors include abdominal obesity, high levels of fats in the blood called triglycerides, ...
Scientists have captured the early death throes of supernovae for the first time and found that the universe's benchmark explosions are much more varied than expected.
The scientists used the Kepler space telescope to photograph three type 1a supernovae in the earliest stages of ignition. They then tracked the explosions in detail to full brightness around three weeks later, and the subsequent decline over the next few months.
They found the initial stages of a supernova explosion did not fit with the existing theories.
"The stars all blow up uniquely. It doesn't ...
DURHAM, N.C. -- Gamers might one day be able to enjoy the same graphics-intensive fast-action video games they play on their gaming consoles or personal computers from mobile devices without guzzling gigabytes, thanks to a new tool developed by researchers at Duke University and Microsoft Research.
Named "Kahawai" after the Hawaiian word for stream, the tool delivers graphics and gameplay on par with conventional cloud-gaming setups for a fraction of the bandwidth.
"That's a huge win, especially if your cellphone plan has a data cap," said Duke computer scientist Landon ...
Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit -- five millilitres to be precise -- to help find the cause and a cure for stuttering.Scientists at the University of Alberta's Institute for Stuttering Treatment and Research (ISTAR) want Albertans to give a spit -- five millilitres to be precise -- to help find the cause and a cure for stuttering.
ISTAR researchers have collected saliva samples from 150 people who stutter and their family members, part of a first-of-its-kind DNA repository ...
Women who choose not to participate in a clinical trial may be significantly more likely to later regret that decision than women who choose to participate in the study, according to a team of Penn State researchers.
The finding may help hospitals and health researchers attract more recruits for clinical trials, a task which many physicians consider the biggest obstacle to conducting these trials, according to the researchers. Typically, as many as 20 percent of a given population of patients are eligible to participate in clinical research. However, of those, only 2 ...
In a state known for its dramatic weather and climate, Colorado's history of extreme precipitation varies considerably by season and location, according to a new study led by the Cooperative Institute for Research in Environmental Science, a partnership between the University of Colorado Boulder and NOAA.
Decision makers -- often facing increased pressure to consider climate change information -- typically turn to historical averages to understand when and where extreme rain, hail and snow happen in the state. But those averages often are not reliable because they're ...
